Vitality Watch

Dossier clinicaltrials trial early 16-jul-2026
Small or early-phase human trial or pilot study

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome

Key claim: A 6-month home-based personalized tDCS intervention targeting the left dorsolateral prefrontal cortex is being tested for effects on cognitive function, dual-task standing and walking, and mobility in older adults with motoric cognitive risk syndrome.

Abstract

The objective of this study is to determine the effects of a 6-month, home-based personalized transcranial direct current stimulation (tDCS) intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in older adults with motoric cognitive risk syndrome (MCR).

Why this matters

Home-based tDCS is moving from clinic-only research into consumer-adjacent territory, and motoric cognitive risk syndrome — a pre-dementia state combining slow gait with subjective cognitive complaints — is exactly the kind of composite endpoint biohacking marketing tends to overclaim on. Tracking this trial matters because it is one of the first structured tests of whether a personalized at-home neuromodulation protocol produces measurable cognitive-plus-mobility gains, rather than the mechanism-plausible hand-waving that currently dominates the space.

Source

Link

Briefing card

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
Stage: trial early · clinicaltrials · 16-jul-2026

A 6-month home-based personalized tDCS intervention targeting the left dorsolateral prefrontal cortex is being tested for effects on cognitive function, dual-task standing and walking, and mobility in older adults with motoric cognitive risk syndrome.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06821568

build build 880 · 2bcef25 · 2026-11-18